$INMD

InMode (INMD) anticipates Q3 2026 revenue of $91.8M-$92M, with full-year revenue projected at $365M-$375M. The consensus estimates are $91.59M for Q3 and $370.27M for the year, according to the company's press release.

InMode Ltd. reported preliminary Q3 2026 revenue of $91.8M-$92.0M and reaffirmed full-year guidance of $365M-$375M. The company will not hold an earnings call due to a strategic proposal review by its special committee. Final results will be released on November 11, 2026, and may differ from preliminary figures.

InMode Ltd. (INMD) launched Morpheus8 Cool, an advanced RF microneedling technology with enhanced comfort and control. The new handpiece features Cool Comfort Technology and an interactive user interface. The company reports high demand and positive feedback from providers.

InMode Ltd. (Nasdaq: INMD) reported Q2 2026 GAAP revenues of $95.6M, unchanged vs Q2 2025. Consumables and service rose 13% to $22.3M. GAAP net income was $17.1M ($0.29/diluted share). Cash and equivalents plus marketable securities totaled $501.1M at June 30, 2026. FY2026 outlook: revenues $365M-$375M and non-GAAP EPS $1.29-$1.34.

InMode Ltd. (INMD) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 YOKNEAM, Israel, August 5, 2026 - InMode Ltd. (Nasdaq: INMD) (“InMode”) , a leading global provider of innovative medical techno

InMode Ltd. (NASDAQ: INMD) said its board received an unsolicited acquisition proposal from Steel Partners Holdings L.P., dated July 9, 2026. A special committee of independent directors will review the proposal with legal and financial advisors. The committee said it will not comment further for now.

InMode Ltd (INMD) shares rose about 4% premarket after Steel Partners Holdings proposed to buy the medical aesthetics company for $16.75 per share in cash, a 20% premium to $13.95 and above a prior $16.20 bid by CEO Moshe Mizrahy. Steel Partners urged an independent committee, questioned governance and possible MNPI around share purchases, and cited 2026 adj. EBITDA of $65M vs guidance $73M-$78M.

InMode Ltd (NASDAQ:INMD) shares rose about 4% premarket after Steel Partners Holdings offered to buy the company for $16.75 per share in cash. Steel Partners, a major shareholder, cited a 20% premium to $13.95 and said it would allow rollover of up to 40% of equity into Steel-owned InMode. It urged an independent committee, challenged CEO Moshe Mizrahy, and referenced 2026 adjusted EBITDA of $65 million versus guidance of $73 million to $78 million.

InMode Ltd., a small-cap Pharmaceuticals & Biotechnology company, has plunged to a new 52-week low of $12.95, marking a 28.66% stock price drop over the past year. This decline follows five consecutive quarters of negative results, including a 67.35% fall in net profit and low operating cash flow. The company’s financial performance significantly underperforms the S&P 500, highlighting challenges in its financial landscape.

InMode (NASDAQ:INMD) shares gapped down following a prior closing price of $15.22, opening at $14.11, and last trading around $14.01. The company's recent earnings reported $0.46 EPS, beating consensus estimates, but revenue slightly missed expectations. Despite a consensus "Hold" rating from analysts with an average target price of $16.80, the stock has seen varied analyst adjustments, including a recent price target cut by UBS Group.